Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

MTK 458 is a PTEN-inducible putative kinase 1 (PINK1) activator.1 It, in combination with the mitochondria uncoupler FCCP (Item No. 15218), increases levels of PINK1 and phosphorylated ubiquitin (pUb) in HeLa cervical cancer cells when used at a concentration of 6.6 µM. MTK 458, in combination with FCCP, induces mitophagy in HeLa cells (EC50 = 0.44 µM). It inhibits doxycycline-induced increases in the mitochondrial levels of insoluble ornithine transcarbamylase (OTC) in HeLa cells when used at concentrations of 25 or 50 µM. In vivo, MTK 458 (50 mg/kg per day) decreases the midbrain levels of total α-synuclein and insoluble α-synuclein aggregates in a mouse model of Parkinson's disease induced by α-synuclein injection in the ipsilateral striatum.
WARNING This product is not for human or veterinary use.
1. Compositions and methods of using the same for treatment of neurodegenerative and mitochondrial disease. (2020).